FINE FOODS & PHARMACEUTICALS (FF.MI) Fundamental Analysis & Valuation

BIT:FF • IT0005215329

Current stock price

9.34 EUR
+0.02 (+0.21%)
Last:

This FF.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FF.MI Profitability Analysis

1.1 Basic Checks

  • FF had positive earnings in the past year.
  • FF had a positive operating cash flow in the past year.
  • In multiple years FF reported negative net income over the last 5 years.
  • Of the past 5 years FF 4 years had a positive operating cash flow.
FF.MI Yearly Net Income VS EBIT VS OCF VS FCFFF.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.84%, FF is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
  • FF's Return On Equity of 12.19% is fine compared to the rest of the industry. FF outperforms 77.78% of its industry peers.
  • FF has a better Return On Invested Capital (8.93%) than 83.33% of its industry peers.
  • FF had an Average Return On Invested Capital over the past 3 years of 5.16%. This is below the industry average of 9.24%.
  • The 3 year average ROIC (5.16%) for FF is below the current ROIC(8.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.84%
ROE 12.19%
ROIC 8.93%
ROA(3y)1.84%
ROA(5y)0.37%
ROE(3y)3.64%
ROE(5y)0.57%
ROIC(3y)5.16%
ROIC(5y)3.56%
FF.MI Yearly ROA, ROE, ROICFF.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5

1.3 Margins

  • FF has a worse Profit Margin (4.35%) than 72.22% of its industry peers.
  • FF's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.05%, FF is doing worse than 72.22% of the companies in the same industry.
  • FF's Operating Margin has improved in the last couple of years.
  • FF's Gross Margin of 35.04% is in line compared to the rest of the industry. FF outperforms 44.44% of its industry peers.
  • FF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.05%
PM (TTM) 4.35%
GM 35.04%
OM growth 3Y768.04%
OM growth 5Y3.56%
PM growth 3YN/A
PM growth 5Y-12.41%
GM growth 3Y9.82%
GM growth 5Y4.32%
FF.MI Yearly Profit, Operating, Gross MarginsFF.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. FF.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FF is destroying value.
  • The number of shares outstanding for FF has been reduced compared to 1 year ago.
  • The number of shares outstanding for FF has been increased compared to 5 years ago.
  • FF has a worse debt/assets ratio than last year.
FF.MI Yearly Shares OutstandingFF.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
FF.MI Yearly Total Debt VS Total AssetsFF.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • FF has an Altman-Z score of 2.91. This is not the best score and indicates that FF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FF has a better Altman-Z score (2.91) than 61.11% of its industry peers.
  • FF has a Debt/Equity ratio of 0.55. This is a neutral value indicating FF is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.55, FF is doing good in the industry, outperforming 61.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 2.91
ROIC/WACC0.99
WACC9.05%
FF.MI Yearly LT Debt VS Equity VS FCFFF.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

2.3 Liquidity

  • FF has a Current Ratio of 1.75. This is a normal value and indicates that FF is financially healthy and should not expect problems in meeting its short term obligations.
  • FF's Current ratio of 1.75 is fine compared to the rest of the industry. FF outperforms 66.67% of its industry peers.
  • A Quick Ratio of 1.23 indicates that FF should not have too much problems paying its short term obligations.
  • FF has a Quick ratio of 1.23. This is in the better half of the industry: FF outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.23
FF.MI Yearly Current Assets VS Current LiabilitesFF.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. FF.MI Growth Analysis

3.1 Past

  • FF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.82%, which is quite impressive.
  • Measured over the past years, FF shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.78% on average per year.
  • The Revenue has been growing slightly by 3.40% in the past year.
  • FF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.95% yearly.
EPS 1Y (TTM)24.82%
EPS 3YN/A
EPS 5Y-3.78%
EPS Q2Q%-63.12%
Revenue 1Y (TTM)3.4%
Revenue growth 3Y6.81%
Revenue growth 5Y7.95%
Sales Q2Q%1.99%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.38% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.58% on average over the next years. This is quite good.
EPS Next Y11.63%
EPS Next 2Y12.87%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue Next Year8.19%
Revenue Next 2Y8.96%
Revenue Next 3Y7.75%
Revenue Next 5Y12.58%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FF.MI Yearly Revenue VS EstimatesFF.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
FF.MI Yearly EPS VS EstimatesFF.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. FF.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • FF is valuated reasonably with a Price/Earnings ratio of 11.97.
  • FF's Price/Earnings ratio is rather cheap when compared to the industry. FF is cheaper than 94.44% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of FF to the average of the S&P500 Index (27.66), we can say FF is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 15.24, the valuation of FF can be described as correct.
  • Based on the Price/Forward Earnings ratio, FF is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of FF to the average of the S&P500 Index (38.00), we can say FF is valued rather cheaply.
Industry RankSector Rank
PE 11.97
Fwd PE 15.24
FF.MI Price Earnings VS Forward Price EarningsFF.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FF indicates a rather cheap valuation: FF is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.69
FF.MI Per share dataFF.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as FF's earnings are expected to grow with 14.38% in the coming years.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y12.87%
EPS Next 3Y14.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. FF.MI Dividend Analysis

5.1 Amount

  • FF has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.
  • FF's Dividend Yield is rather good when compared to the industry average which is at 0.48. FF pays more dividend than 100.00% of the companies in the same industry.
  • FF's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

  • The dividend of FF has a limited annual growth rate of 3.73%.
Dividend Growth(5Y)3.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • FF pays out 20.96% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of FF is growing, but earnings are growing more, so the dividend growth is sustainable.
DP20.96%
EPS Next 2Y12.87%
EPS Next 3Y14.38%
FF.MI Yearly Income VS Free CF VS DividendFF.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M
FF.MI Dividend Payout.FF.MI Dividend Payout, showing the Payout Ratio.FF.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FF.MI Fundamentals: All Metrics, Ratios and Statistics

FINE FOODS & PHARMACEUTICALS

BIT:FF (4/22/2026, 5:25:14 PM)

9.34

+0.02 (+0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-11
Earnings (Next)05-06
Inst Owners12.28%
Inst Owner ChangeN/A
Ins Owners53.17%
Ins Owner ChangeN/A
Market Cap206.04M
Revenue(TTM)376.07M
Net Income(TTM)16.36M
Analysts84.62
Price Target13.26 (41.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend0.14
Dividend Growth(5Y)3.73%
DP20.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.09%
PT rev (3m)5.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.21%
EPS NY rev (3m)-12.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.83%
Revenue NY rev (3m)-6.19%
Valuation
Industry RankSector Rank
PE 11.97
Fwd PE 15.24
P/S 0.55
P/FCF N/A
P/OCF 6.49
P/B 1.54
P/tB 1.71
EV/EBITDA 5.69
EPS(TTM)0.78
EY8.35%
EPS(NY)0.61
Fwd EY6.56%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.44
OCFY15.41%
SpS17.05
BVpS6.08
TBVpS5.47
PEG (NY)1.03
PEG (5Y)N/A
Graham Number10.3329 (10.63%)
Profitability
Industry RankSector Rank
ROA 5.84%
ROE 12.19%
ROCE 12.45%
ROIC 8.93%
ROICexc 10.92%
ROICexgc 11.84%
OM 7.05%
PM (TTM) 4.35%
GM 35.04%
FCFM N/A
ROA(3y)1.84%
ROA(5y)0.37%
ROE(3y)3.64%
ROE(5y)0.57%
ROIC(3y)5.16%
ROIC(5y)3.56%
ROICexc(3y)6.08%
ROICexc(5y)4.55%
ROICexgc(3y)6.67%
ROICexgc(5y)5.1%
ROCE(3y)7.21%
ROCE(5y)4.98%
ROICexgc growth 3Y752.36%
ROICexgc growth 5Y-1.51%
ROICexc growth 3Y767.35%
ROICexc growth 5Y-2.74%
OM growth 3Y768.04%
OM growth 5Y3.56%
PM growth 3YN/A
PM growth 5Y-12.41%
GM growth 3Y9.82%
GM growth 5Y4.32%
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 1.65
Cap/Depr 199.81%
Cap/Sales 9.57%
Interest Coverage 250
Cash Conversion 71.35%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.23
Altman-Z 2.91
F-Score7
WACC9.05%
ROIC/WACC0.99
Cap/Depr(3y)177.42%
Cap/Depr(5y)150.87%
Cap/Sales(3y)12.01%
Cap/Sales(5y)10.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.82%
EPS 3YN/A
EPS 5Y-3.78%
EPS Q2Q%-63.12%
EPS Next Y11.63%
EPS Next 2Y12.87%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue 1Y (TTM)3.4%
Revenue growth 3Y6.81%
Revenue growth 5Y7.95%
Sales Q2Q%1.99%
Revenue Next Year8.19%
Revenue Next 2Y8.96%
Revenue Next 3Y7.75%
Revenue Next 5Y12.58%
EBIT growth 1Y12.08%
EBIT growth 3Y827.16%
EBIT growth 5Y11.79%
EBIT Next Year93.49%
EBIT Next 3Y33.32%
EBIT Next 5Y24.63%
FCF growth 1Y-138.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.73%
OCF growth 3Y104.97%
OCF growth 5Y0.84%

FINE FOODS & PHARMACEUTICALS / FF.MI Fundamental Analysis FAQ

What is the fundamental rating for FF stock?

ChartMill assigns a fundamental rating of 5 / 10 to FF.MI.


Can you provide the valuation status for FINE FOODS & PHARMACEUTICALS?

ChartMill assigns a valuation rating of 6 / 10 to FINE FOODS & PHARMACEUTICALS (FF.MI). This can be considered as Fairly Valued.


What is the profitability of FF stock?

FINE FOODS & PHARMACEUTICALS (FF.MI) has a profitability rating of 5 / 10.


What is the valuation of FINE FOODS & PHARMACEUTICALS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FINE FOODS & PHARMACEUTICALS (FF.MI) is 11.97 and the Price/Book (PB) ratio is 1.54.


Can you provide the expected EPS growth for FF stock?

The Earnings per Share (EPS) of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 11.63% in the next year.